[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pre-Filled Syringes Ecosystem Analysed by SNS Research in New Report Published at MarketPublishers.com

06 Nov 2014 • by Natalie Aster

LONDON – Constituting one of the most rapidly growing segments of the injectable drug delivery universe, pre-filled syringes offer considerable benefits over the conventional vial-and-syringe format, by improving dosing accuracy, convenience and safety. Additionally, pre-filled syringes bring a wide scope of economic benefits to pharma companies, such as a reduction in the amount of drug overfill and waste, which boosts the saleable yield of the API. Despite challenges pertaining to drug stability, production and competition from a slew of drug delivery technologies, the market is expected to see huge growth in the years to come.  The revenue from the pre-filled syringes market is forecast to reach more than USD 3.2 billion by 2015-end and account for around USD 6 billion by 2020, growing at a CAGR of 13% during 2015-2020.

A great many pre-filled syringe makers are now offering integrated automatic needle shielding systems or retractable needles. Whilst glass keeps on remaining the gold standard for pre-filled syringes, the proportion of plastic based pre-filled syringes will likely grow by 5% from 2015 to 2020, owing to concerns over plunger failure and glass breakage. A number of pre-filled syringe producers have created dual- and multi-chambered syringes, to cater for drugs to be reconstituted at the POD. Pre-filled pen systems and auto-injectors are poised for over 20% CAGR in the next five years.

New study “The Pre-Filled Syringes Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” prepared by SNS Research provides an in-depth evaluation of the global pre-filled syringes universe. It provides comprehensive insights into the technology, market driving factors and challenges, investment potential, major therapies, use cases, opportunities, industry outlook, value chain, profiles of the top 55 market players’ (manufacturers and pharma giants) alongside their leading strategies. The study also presents detailed forecast figures for pre-filled syringe unit sales through to 2030. The forecasts are then segmented for 4 submarkets (by material and injector type), 10 drug classes, 5 regions and 13 major nations. Strategic recommendations are also included.

Report Details:

The Pre-Filled Syringes Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts
Published: November, 2014
Pages: 147
Price: US$ 2,500.00

More new reports by the publisher can be found at SNS Research page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 

Analytics & News

Weekly Digest